• search

Cosmetic results good with partial-breast radiation

Written by: Staff
|

NEW YORK, Mar 21 (Reuters) As a treatment for early breast cancer, accelerated partial-breast irradiation (APBI) results in good to excellent cosmetic outcomes in nearly all patients and is associated with only mild toxic effects, new research shows.

With APBI, radioactive ''seeds'' are placed in the breast that deliver radiation to the tumor site instead of to the whole breast as typically occurs with standard radiation therapy.

''These results of patients who received APBI...closely parallel the results from several single-institutional experiences along with a phase III randomized trial, all of which demonstrated its 5-year efficacy in selected patients,'' lead author Dr. Peter Y. Chen and colleagues, from William Beaumont Hospital in Royal Oak, Michigan, write in the medical journal Cancer.

The findings are based on a study of 199 women treated with APBI after having their breast cancer surgically removed with ''lumpectomy,'' an operation that removes just the tumor, leaving most of the breast intact. APBI was applied to the tumor area using low- or high-dose seeds.

After approximately 6 years of follow-up, 33 per cent of cosmetic outcomes were excellent, 66 percent were good, and 1 per cent were fair, the researchers state.

Breast pain, swelling, redness, and skin pigment changes were common findings following APBI, but all decreased over time, the report indicates. Infections were generally mild and were largely confined to the first month after APBI, the report indicates. The long-term side effects treatment were mild and most diminished or reached a plateau over time.

Overall, the researchers conclude that the cosmetic outcomes with APBI are good or excellent in nearly all patients.

Reuters PR DB0852

For Daily Alerts

For Breaking News from Oneindia
Get instant news updates throughout the day.

Notification Settings X
Time Settings
Done
Clear Notification X
Do you want to clear all the notifications from your inbox?
Settings X
We use cookies to ensure that we give you the best experience on our website. This includes cookies from third party social media websites and ad networks. Such third party cookies may track your use on Oneindia sites for better rendering. Our partners use cookies to ensure we show you advertising that is relevant to you. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on Oneindia website. However, you can change your cookie settings at any time. Learn more